Piqray

AZ's first-in-class breast cancer approval marred by restriction

AstraZeneca's Truqap is the first AKT inhibitor to win an FDA nod. But a biomarker restriction from the FDA came as a surprise.

Angus Liu Nov 17, 2023 11:02am

Novartis' new rare disease drug Vijoice meant as 'blank canvas'

Aug 10, 2022 10:29am

Piqray

Novartis gains FDA approval for Vijoice for rare condition PROS

Apr 6, 2022 9:19am

Novartis rare disease comic book cover PIK3CA mutations

Novartis' rare disease campaign draws on comic book characters

Aug 30, 2021 9:50am

Novartis social media campaign on breast cancer health inequities

Novartis' campaign tackles inequities in breast cancer health

Jun 14, 2021 8:00am

Novartis MBC campaign on Instagram 2020

Novartis launches metastatic breast cancer Instagram series

Oct 23, 2020 8:06am